CVAS (CVAS) Stock Price & Analysis
CVAS (CVAS) rose 0.00% to USD 0 as of June 10, 2026 at 03:28 UTC, according to Nexqual real-time market data.
CVAS last closed at USD 0; the session ranged USD 0–0 on volume of 33,100 shares. Market capitalization is $14,995, with a 52-week range of USD 0–0 (PNK). Source: Nexqual, June 10, 2026 at 03:28 UTC.
Key Statistics (as of June 10, 2026 at 03:28 UTC)
| Price | USD 0 |
|---|---|
| Change | ▲ 0.00% (up) |
| Previous Close | USD 0 |
| Open | USD 0 |
| Day Range | USD 0 – 0 |
| 52-Week Range | USD 0 – 0 |
| Volume | 33,100 shares |
| Market Cap | $14,995 |
| Exchange | PNK |
Technical Analysis (CVAS)
Nexqual's technical model rates CVAS "STRONG SELL" based on 0 bullish and 5 bearish signals across 124 daily candles, as of June 10, 2026 at 03:28 UTC.
| Overall Signal | STRONG SELL |
|---|---|
| RSI (14) | 100 (overbought) |
| vs SMA50 | Below (USD 0) |
| MACD | 0 (negative) |
Analyst Ratings (CVAS)
Wall Street analysts rate CVAS "None", per Nexqual as of June 10, 2026 at 03:28 UTC.
| Consensus Rating | None |
|---|
Earnings (CVAS)
Source: Nexqual, June 10, 2026 at 03:28 UTC.
Financials & Fundamentals (CVAS)
| Total Revenue | $5.44M |
|---|---|
| Revenue Growth (YoY) | -13.30% |
| Gross Margin | +33.84% |
| Operating Margin | -18.70% |
| Profit Margin | -8.98% |
| Current Ratio | 0.72 |
| Total Cash | $1.08M |
| Total Debt | $3.60M |
| Free Cash Flow | $-131,107 |
Source: Nexqual, June 10, 2026 at 03:28 UTC.
Financial Health Score (CVAS)
Nexqual rates CVAS's overall financial health "Weak" across five dimensions, as of June 10, 2026 at 03:28 UTC.
| Growth | Critical — Revenue -13% YoY (latest Q), sharp decline |
|---|---|
| Profitability | Weak — Not yet profitable — scaling phase |
| Balance Sheet | Mixed — $1M cash vs $4M debt |
| Cash Flow | Weak — FCF negative: -$131K, burning cash |
| Efficiency | Mixed — No data |
Ownership (CVAS)
| Insider Ownership | +26674.70% |
|---|---|
| Institutional Ownership | +0.00% |
| Shares Outstanding | 37.49M |
Source: Nexqual, June 10, 2026 at 03:28 UTC.
Leadership (CVAS)
CVAS is led by Dominic Burns (age 65), CEO, President & Director, per Nexqual as of June 10, 2026 at 03:28 UTC.
| CEO, President & Director | Dominic Burns (age 65) |
|---|---|
| CFO, Principal Accounting Officer, Secretary & Director | Heung Hung Lee (age 56) |
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| SANG | Sangoma Technologies Corporatio | USD 3.46 | ▼ 1.14% |
| MAGN | Magnera Corporation | USD 11.7 | ▲ 4.28% |
| IGEN | iGen Networks Corp. | USD 0 | ▲ 0% |
| EMIS | Emmis Acquisition Corp. | USD 10.15 | ▲ 0.2% |
| ATRX | Adhera Therapeutics Inc. | USD 0 | ▲ 0% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: June 10, 2026 at 03:28 UTC. This page is informational and not investment advice.